The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.
- 15 June 1985
- journal article
- Vol. 132 (12) , 1373-7
Abstract
Testing for antibody to human T-lymphotropic retrovirus (HTLV-III) was carried out in 448 participants in the Vancouver Lymphadenopathy-AIDS (acquired immune deficiency syndrome) Study. The overall prevalence rate of seropositivity was 34%. Of 130 seronegative subjects followed for an average of 8.5 months, 14 became seropositive; thus, the approximate annual seroconversion rate was 15%. More than 100 male sexual partners in one's lifetime, frequent receptive anal intercourse, fisting, a history of gonorrhea or hepatitis, and frequent sexual contact in clubs were found to be independent risk factors for HTLV-III seropositivity.This publication has 11 references indexed in Scilit:
- HTLV-III ANTIBODY FREQUENCY AND SEVERITY OF LYMPHADENOPATHYThe Lancet, 1984
- Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.BMJ, 1984
- DETERMINANTS OF RETROVIRUS (HTLV-III) ANTIBODY AND IMMUNODEFICIENCY CONDITIONS IN HOMOSEXUAL MENThe Lancet, 1984
- Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDSScience, 1984
- Kaposi's Sarcoma in Homosexual MenAnnals of Internal Medicine, 1984
- Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDSScience, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- RISK FACTORS FOR KAPOSI'S SARCOMA IN HOMOSEXUAL MENThe Lancet, 1982
- Statistical Aspects of the Analysis of Data From Retrospective Studies of DiseaseJNCI Journal of the National Cancer Institute, 1959